New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary diseaseBusiness Wire • 05/19/24
BenevolentAI and AstraZeneca discover novel heart failure target using AIProactive Investors • 05/15/24
Eli Lilly's and AstraZeneca's Former Head of Research Dr. Jan Lundberg Elected as a New Board MemberAccesswire • 05/15/24
AstraZeneca to withdraw its COVID-19 vaccine globally as demand dips, rare side effects revealedFox Business • 05/08/24
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominanceCNBC • 05/07/24